Brian Horger, PhD

Chief Executive Officer

Brian A. Horger, PhD, brings extensive experience in drug development across the CRO and pharmaceutical industry. Dr. Horger has held research and development positions at Yale University School of Medicine, Genentech, and Theravance Biopharma, leading discovery programs for novel therapeutic candidates targeting Neurology and smooth muscle disorders. Before joining InClin, Dr. Horger served as Director of Business Development at MDS Pharma Services, Radiant Research, and Covance. He holds a PhD in Neuroscience from Texas A&M University.